Latest Acquisition News

Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.

Resolution Minerals Ltd has responded to an ASX price query following a significant jump in its share price and trading volume, confirming no undisclosed material information. The company attributes the surge to sector-wide momentum and recent diplomatic engagements.

ARB Corporation Limited reported a 5.3% increase in FY25 sales revenue to A$729.9 million, driven by strong export growth and strategic US market moves, despite a 5% dip in profit after tax.

Power Minerals Limited (PNN) has been invited to brief the Australian Ambassador to the US on its strategic Gamma Heavy Rare Earths Project in California, underscoring the project's growing importance in Australia-US critical minerals cooperation ahead of the Prime Minister's meeting with President Trump.

Enero Group’s 2025 AGM revealed a modest revenue dip but a rise in EBITDA, driven by operational improvements and AI innovation. The company’s FY26 Q1 update signals robust momentum with margin expansion and strategic client wins.

Treasury Wine Estates reported robust fiscal 2025 results driven by luxury wine growth and acquisitions, yet has downgraded its fiscal 2026 earnings outlook due to weakening demand in China and distribution disruptions in California.

Mount Gibson Iron Limited has agreed to acquire a 50% interest in the Central Tanami Gold Project, marking a strategic shift towards gold production while maintaining steady iron ore operations at Koolan Island.

Blue Star Helium Limited is advancing its Galactica helium project in Colorado, aiming for initial commercial production by December 2025, supported by a recent A$4.5 million equity raise.

NSX Limited’s shares have been suspended from trading following Federal Court approval of its acquisition by an Ontario-based entity linked to CNSX Markets Inc. This marks a significant shift in ownership for the Australian stock exchange operator.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Aurumin Limited has sent out its Scheme Booklet detailing the proposed acquisition by Brightstar Resources, setting the stage for shareholder meetings in November. Securityholders are urged to review the materials carefully before voting.

Peppermint Innovation Limited (PIL) has addressed recent unusual trading activity, attributing it to growing market recognition of its recent fintech milestones rather than undisclosed information.